SCHEMBL19081814

SCHEMBL19081814

c1ccc2cc(-c3c4ccccc4c(-c4c5oc6ccccc6c5cc5c4sc4ccc6ccccc6c45)c4ccccc34)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
CYP1A1 P04798 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP1B1 Q16678 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ABCG2 Q9UNQ0 3/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
AHR P35869 2/20 0.31
PAX8 Q06710 2/20 0.31
NQO1 P15559 1/20 0.30
NQO2 P16083 1/20 0.30
FYN P06241 1/20 0.30
MAPK3 P27361 1/20 0.30
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081974 0.96 NPC1 (0.34) NPC1RAB9ACYP1A1CYP1A2CYP1B1
SCHEMBL19081865 0.85 ABCG2 (0.34) CYP1A1CYP1A2TDP1L3MBTL1ABCG2
SCHEMBL19081956 0.84 ALOX5 (0.33) CYP1A1CYP1A2TDP1L3MBTL1ABCG2
SCHEMBL17945170 0.83 CYP1A2 (0.36) NPC1RAB9ACYP1A1CYP1A2CYP1B1
SCHEMBL19081470 0.83 CYP1A1 (0.39) NPC1RAB9ACYP1A1CYP1A2CYP1B1
SCHEMBL19076854 0.83 CYP1A1 (0.34) NPC1RAB9ACYP1A1CYP1A2CYP1B1
SCHEMBL19081807 0.82 CYP1A1 (0.38) NPC1RAB9ACYP1A1CYP1A2CYP1B1
SCHEMBL10122341 0.82 AHR (0.41) NPC1RAB9ACYP1A1CYP1A2CYP1B1
SCHEMBL19076728 0.82 NPC1 (0.33) NPC1RAB9ACYP1A1CYP1A2CYP1B1
SCHEMBL19081988 0.82 TDP1 (0.34) NPC1RAB9ACYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NPC1 1508/4885RAB9A 3068/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NPC1 1508/4885RAB9A 3068/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.